(NASDAQ:KSPI),(NYSE:SUI),(NASDAQ:MGPI),(NASDAQ:SAVA), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Joint Stock Company Kaspi.kz (NASDAQ:KSPI), Sun Communities (NYSE: SUI), Cassava Sciences, Inc (NASDAQ: SAVA), and MGP Ingredients, Inc. (NASDAQ: MGPI). Stockholders […]

(NYSE:CUBI),(NASDAQ:AEHR),(NasdaqGM:SYM),(NASDAQ:ASPI), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Aehr Test Systems, Inc. (NASDAQ: AEHR), Customers Bancorp, Inc. (NYSE:CUBI), Symbotic Inc. (NASDAQ: SYM), and ASP Isotopes, Inc (NASDAQ: ASPI). Stockholders

(NasdaqGM:QTRX),(NasdaqGM:TMDX), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Quanterix Corporation (NASDAQ:QTRX) and TransMedics Group, Inc. (NASDAQ:TMDX). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information

(NasdaqGM:CDLX), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ:CDLX) in the United States District Court for the Northern District of Georgia on behalf of all persons

(NASDAQ:REGN), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on behalf of long-term stockholders following a class action complaint that was filed against Regeneron on January 7, 2025 with a Class Period from November

(NASDAQ:EPIX), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against ESSA Pharma Inc. (“ESSA” or the “Company”) (NASDAQ:EPIX) in the United States District Court for the Eastern District of Wisconsin on behalf of all

(NYSE:YOU), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Clear Secure, Inc. (“Clear” or the “Company”) (NYSE:YOU) on behalf of Clear stockholders. Our investigation concerns whether Clear has violated the federal securities laws and/or engaged in other unlawful

Report on how AI is redefining market landscape – The global express delivery market in europesize is estimated to grow by USD 18.91 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over 5.4% during the forecast period. Growth of e-commerce industry in Europe is driving market growth,

(NASDAQ:MGPI), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MGP Ingredients, Inc. (NASDAQ: MGPI) between May 4, 2023 and October 30, 2024 (the “Class Period”), of the important February 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased

Shinji Sashida newly appointed as President and CEO Sony Group Corporation and Sony Semiconductor Solutions Corporation (“SSS”) today announced that Shinji Sashida, currently SSS Director, Executive Deputy President, has been appointed as Representative Director, President and CEO of SSS, effective April 1, 2025. Terushi Shimizu, currently serving as Representative Director, President and CEO, will become